Novo Nordisk announced that people with diabetes using Novo insulins, who have lost health insurance coverage because of a change in job status due to COVID-19, may be eligible for enrollment in their Diabetes Patient Assistance Program (PAP). That would provide insulin free-of-charge for 90 days.

Patients who wish to use this program will only need to provide a notice of insurance termination or a COBRA notification. Novo Nordisk will not require documented proof of income to qualify.

Eligible patients will receive their insulin at no cost for 90 days. Assistance can be extended to the end of 2020 if Medicaid benefits have been denied, and Medicare patients will be enrolled for the rest of 2020.

Find out if you meet eligibility criteria at NovoCare.com or by calling 1-844-668-6463.